Hercules Capital (NYSE:HTGC) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.36 by 8.33 percent. This is a 18.18 percent increase over earnings of $0.33 per share from the same period last year.
Seelos Therapeutics Announces $4.5M Registered Direct Offering Of Common Stock And Warrants To Purchase Common Stock
Seelos Therapeutics, Inc. (NASDAQ:SEEL) ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system (CNS) disorders and rare diseases, today announced that it
